These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15094825)

  • 1. On the peptide-antipeptide interactions in interleukin-1 receptor system.
    Kluczyk A; Cebrat M; Zbozień-Pacamaj R; Lisowski M; Stefanowicz P; Wieczorek Z; Siemion IZ
    Acta Biochim Pol; 2004; 51(1):57-66. PubMed ID: 15094825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The search for inhibitors of interleukin-1 based on the sequence of interleukin-1 receptor antagonist.
    Wieczorek Z; Kluczyk A; Slon-Usakiewicz JJ; Siemion IZ
    Biomed Pept Proteins Nucleic Acids; 1996-1997; 2(4):123-9. PubMed ID: 9575352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulatory activity of oligopeptides related to interleukin 1 receptor antagonist sequence.
    Kluczyk A; Siemion IZ; Słoń-Usakiewicz JJ; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1997; 45(5-6):427-33. PubMed ID: 9437498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De-novo design of complementary (antisense) peptide mini-receptor inhibitor of interleukin 18 (IL-18).
    Bhakoo A; Raynes JG; Heal JR; Keller M; Miller AD
    Mol Immunol; 2004 Nov; 41(12):1217-24. PubMed ID: 15482857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunosuppressive activity of peptide fragments of vaccinia virus C10L protein and a hypothesis on the role of this protein in the viral invasion.
    Kluczyk A; Siemion IZ; Szewczuk Z; Wieczorek Z
    Peptides; 2002 May; 23(5):823-34. PubMed ID: 12084512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A hexapeptide VTKFYF from C-terminal part of interleukin-1 receptor antagonist, an inhibitor of IL-1-IL-1 receptor interaction.
    Wieczorek Z; Kluczyk A; Słoń-Usakiewicz JJ; Siemion IZ
    Pol J Pharmacol; 1997; 49(2-3):107-17. PubMed ID: 9437757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1beta.
    Vigers GP; Anderson LJ; Caffes P; Brandhuber BJ
    Nature; 1997 Mar; 386(6621):190-4. PubMed ID: 9062193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist.
    Smeets RL; Joosten LA; Arntz OJ; Bennink MB; Takahashi N; Carlsen H; Martin MU; van den Berg WB; van de Loo FA
    Arthritis Rheum; 2005 Jul; 52(7):2202-11. PubMed ID: 15986350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of interleukin-2/p55 receptor subunit interaction by complementary peptides.
    Fassina G; Cassani G; Gnocchi P; Fornasiero MC; Isetta AM
    Arch Biochem Biophys; 1995 Apr; 318(1):37-45. PubMed ID: 7726570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling of fish interleukin-1 and its receptor.
    Scapigliati G; Costantini S; Colonna G; Facchiano A; Buonocore F; Bossù P; Cunningham C; Holland JW; Secombes CJ
    Dev Comp Immunol; 2004 May; 28(5):429-41. PubMed ID: 15062642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New hypothesis on amino acid complementarity and its evaluation on TGF-beta(2)-related peptides.
    Siemion IZ; Zbozień-Pacamaj R; Stefanowicz P
    J Mol Recognit; 2001; 14(1):1-12. PubMed ID: 11180557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monotonicity of interleukin-1 receptor-ligand binding with respect to antagonist in the presence of decoy receptor.
    Gnacadja G; Shoshitaishvili A; Gresser MJ; Varnum B; Balaban D; Durst M; Vezina C; Li Y
    J Theor Biol; 2007 Feb; 244(3):478-88. PubMed ID: 17011587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and characterization of a fusion protein between thermally responsive elastin-like polypeptide and interleukin-1 receptor antagonist: sustained release of a local antiinflammatory therapeutic.
    Shamji MF; Betre H; Kraus VB; Chen J; Chilkoti A; Pichika R; Masuda K; Setton LA
    Arthritis Rheum; 2007 Nov; 56(11):3650-61. PubMed ID: 17968946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 1 (IL-1) causes changes in lateral and rotational mobilities of IL-1 type I receptors.
    Guo C; Georgiadis KE; Dower SK; Holowka D; Baird BA
    Biochemistry; 1999 Feb; 38(5):1618-25. PubMed ID: 9931029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of interleukin-1 receptor antagonist mutants with enhanced antagonistic activity in vitro and improved therapeutic efficacy in collagen-induced arthritis.
    Dahlén E; Barchan K; Herrlander D; Höjman P; Karlsson M; Ljung L; Andersson M; Bäckman E; Hager AC; Walse B; Joosten L; van den Berg W
    J Immunotoxicol; 2008 Apr; 5(2):189-99. PubMed ID: 18569390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anion binding and controlled aggregation of human interleukin-1 receptor antagonist.
    Raibekas AA; Bures EJ; Siska CC; Kohno T; Latypov RF; Kerwin BA
    Biochemistry; 2005 Jul; 44(29):9871-9. PubMed ID: 16026159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiating role of interleukin-1beta (IL-1beta) and IL-1beta type 1 receptors in the medial hypothalamus in defensive rage behavior in the cat.
    Hassanain M; Bhatt S; Zalcman S; Siegel A
    Brain Res; 2005 Jun; 1048(1-2):1-11. PubMed ID: 15919060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A search within the IL-1 type I receptor reveals a peptide with hydropathic complementarity to the IL-1beta trigger loop which binds to IL-1 and inhibits in vitro responses.
    Heal JR; Bino S; Ray KP; Christie G; Miller AD; Raynes JG
    Mol Immunol; 1999 Dec; 36(17):1141-8. PubMed ID: 10698316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
    Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational perturbation of interleukin-2: a strategy for the design of cytokine analogs.
    Landgraf BE; Williams DP; Murphy JR; Smith KA; Ciardelli TL
    Proteins; 1991; 9(3):207-16. PubMed ID: 2006138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.